Arena Pharmaceuticals IncArena Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This ESG assessment for Arena Pharmaceuticals Inc indicates the company's transparency towards the UN SDGs. Comprehensive ESG assessment of Arena Pharmaceuticals Inc can be accessed by registering for free. Check the end of the webpage for potential risks for Arena Pharmaceuticals Inc based on sector, location and marketcap.

Arena Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 1.1, social score of 4.0 and governance score of 6.0.

SDG Transparency Score for Arena Pharmaceuticals Inc 

3.9

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Arena Pharmaceuticals Inc 
1.1

Environmental

4.0

Social

6.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1443XSpray Pharma AB (publ)
4.0
High
1443Zhong Yuan Bio-Technology Holdings Ltd
4.0
High
.........
1476Arena Pharmaceuticals Inc
3.9
Medium
1476Anebulo Pharmaceuticals Inc
3.9
Medium
1476Anhui Sunhere Pharmaceutical Excipients Co Ltd
3.9
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Arena Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc offer flexible work?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose water use targets?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Arena Pharmaceuticals Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Arena Pharmaceuticals Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Arena Pharmaceuticals Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose its waste policy?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Arena Pharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Arena Pharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Arena Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase I clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with Second Genome, Inc.; United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; Eisai Inc.; and Aristea Therapeutics, Inc. for the development of RIST4721 for treatment of serious immune-mediated inflammatory diseases. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah.

Sorry!

Failed to process!